mortality/aging
|
• homozygotes are embryonic lethal
• 17% of embryos die by E12.5 and 71% of embryos die by E13.5
|
|
• 17% of embryos die by E12.5
|
growth/size/body
|
• embryo size is reduced at E12.5 and E13.5 compared to age-matched control embryos
|
endocrine/exocrine glands
|
• adrenal primordia in E13.5 embryos are significantly smaller
|
absent ovary
(
J:135449
)
|
|
|
embryo
|
• embryo size is reduced at E12.5 and E13.5 compared to age-matched control embryos
|
reproductive system
absent ovary
(
J:135449
)
|
|
|
renal/urinary system
|
• E13.5 embryos fail to develop a metanephros
|
cardiovascular system
|
• cardiac dysplasia is noted in all embryos at E13.5
• both ventricles have poorly developing compact and trabecular myocardium in the free walls
• atrial cavaties are dilated with thickened epicardium
• other cardiac abnormalities noted in E13.5 embryos are hypoplastic myocardium, heart shape abnormalities with rounded apex, and improper epicardium and mesocardial attachment
|
|
• rounded heart apex
|
|
• pericardial hemorrhaging in about half the embryos
|
liver/biliary system
|
• the livers of E12.5 and E13.5 embryos are hypoplastic and deficient in lobation
|
muscle
|
• diaphragms are incompletely formed in all embryos at E12.5 with an increase in the dorsolateral gap
• E13.5 embyros have large openings between the pleural and peritoneal spaces
|
homeostasis/metabolism
|
• pericardial hemorrhaging in about half the embryos
|


Analysis Tools